Staurosporine inhibition of zipper-interacting protein kinase contractile effects in gastrointestinal smooth muscle

Biochemistry and Cell Biology

Volumn 85, Issue 1, 2007, Pages 111-120

  Borman, Meredith A ^a   MacDonald, Justin A ^a   Haystead, Timothy A J ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Calcium sensitization; Ileum; Smooth muscle; Zipper interacting protein kinase

Indexed keywords

CALCIUM SENSITIZATION; PROTEIN KINASE; VASCULAR SMOOTH MUSCLE; ZIPPER-INTERACTING PROTEIN KINASE (ZIPK);

CALCIUM; ENZYME INHIBITION; GASTROENTEROLOGY; IONS; PHOSPHORYLATION;

MUSCLE;

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; LEUCINE ZIPPER PROTEIN; MYOSIN; PHOSPHOLIPID; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; RHO KINASE; STAUROSPORINE; UNCLASSIFIED DRUG; ZIPPER INTERACTING PROTEIN KINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ILEUM; IN VITRO STUDY; INTESTINE MUSCLE; MUSCLE CONTRACTILITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; CALCIUM; ENZYME ACTIVATION; ILEUM; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MUTATION; MYOSIN LIGHT CHAINS; PERMEABILITY; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RABBITS; RECOMBINANT PROTEINS; STAUROSPORINE;

EID: 34249945412     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/O06-209     Document Type: Article

References (29)

1. 2+ sensitization via myosin phosphatase inhibition. J. Biol. Chem. 277: 23441-23446. doi:10.1074/jbc.M201597200.
2. Brooks, S.P.J. 1992. A simple computer program with statistical tests for the analysis of enzyme kinetics. Biotechniques, 13: 906-911.
3. Endo, A., Surks, H.K., Mochizuki, S., Mochizuki, N., and Mendelsohn, M.E. 2004. Identification and characterization of zipper-interacting protein kinase as the unique vascular smooth muscle myosin phosphatase-associated kinase. J. Biol. Chem. 279: 42055-42061. doi:10.1074/jbc.M403676200.
4. Hanks, S.K., Quinn, A.M., and Hunter, T. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science (Washington, D.C.), 241: 42-52. doi:10.1126/science.3291115.
5. Harada, T., Seto, M., Sasaki, Y., London, S., Luo, Z., and Mayberg, M. 1995. The time course of myosin light-chain phosphorylation in blood-induced vasospasm. Neurosurgery, 36: 1178-1183.
6. Haystead, T.A.J. 2005. ZIP kinase, a key regulator of myosin protein phosphatase 1. Cell. Signal. 17: 1313-1322.
7. Hosseini, J.M., Goldhill, J.M., Bossone, C., Pineiro-Carrero, V., and Shea-Donohue, T. 1999. Progressive alterations in circular smooth muscle contractility in TNBS-induced colitis in rats. Neurogastroenterol. Motil. 11: 347-356. doi:10.1046/j.1365-2982.1999.00165.x.
8. i-coupled receptors mediate phosphorylation of CPI-17 and MLC20 via preferential activation of the PI3K/ILK pathway. Biochem. J. 396: 193-200.
9. Ikebe, M., and Hartshorne, D.J. 1985. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J. Biol. Chem. 260: 10027-10031.
10. Ito, M., Nakano, T., Erdodi, F., and Hartshorne, D.J. 2004. Myosin phosphatase: structure, regulation and function. Mol. Cell. Biochem. 259: 197-209. doi:10.1023/B:MCBI.0000021373.14288.00.
11. Karim, S.M., Rhee, A.Y., Given, A.M., Faulx, M.D., Hoit, B.D., and Brozovich, F.V. 2004. Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ. Res. 95: 612-618. doi:10.1161/01.RES. 0000142736.39359.58.
12. Katsumata, N., Shimokawa, H., Seto, M., Kozai, T., Yamawaki, T., Kuwata, K., et al. 1997. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β. Circulation, 96: 4357-4363.
13. Kawai, T., Matsumoto, M., Takeda, K., Sanjo, H., and Akira, S. 1998. ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol. Cell. Biol. 18: 1642-1651.
14. Kawai, T., Akira, S., and Reed, J.C. 2003. ZIP kinase triggers apoptosis from nuclear PML oncogenic domains. Mol. Cell. Biol. 23: 6174-6186. doi:10.1128/MCB.23.17.6174-6186.2003.
15. Kim, N., Cao, W., Song, I.S., Kim, C.Y., Harnett, K.M., Cheng, L., Walsh, M.P., and Biancani, P. 2004. Distinct kinases are involved in contraction of cat esophageal and lower esophageal sphincter smooth muscles. Am. J. Physiol. Cell Physiol. 287: C384-C394. doi:10.1152/ajpcell.00390.2003.
16. Komatsu, S., and Ikebe, M. 2004. ZIP kinase is responsible for the phosphorylation of myosin II and necessary for cell motility in mammalian fibroblasts. J. Cell Biol. 165: 243-254. doi:10.1083/jcb.200309056.
17. Kureishi, Y., Ito, M., Feng, J., Okinaka, T., Isaka, N., and Nakano, T. 1999. Regulation of calcium independent smooth muscle contraction by alternative staurosporine-sensitive kinases. Eur. J. Pharmacol. 376: 315-320. doi:10.1016/S0014-2999(99)00367-2.
18. MacDonald, J.A., Borman, M.A., Murányi, A., Somlyo, A.V., Hartshorne, D.J., and Haystead, T.A.J. 2001a. Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc. Natl. Acad. Sci. U.S.A. 98: 2419-2424. doi:10.1073/pnas.041331498.
19. MacDonald, J.A., Eto, M., Borman, M.A., Brautigan, D.L., and Haystead, T.A.J. 2001b. Dual Ser and Thr phosphorylation of CPI-17, an inhibitor of myosin phosphatase, by MYPT-associated kinase. FEBS Lett. 493: 91-94. doi:10.1016/S0014-5793(01)02277-3.
20. Murata-Hori, M., Suizu, F., Iwasaki, T., Kikuchi, A., and Hosoya, H. 1999. ZIP kinase identified as a novel myosin regulatory light chain kinase in HeLa cells. FEBS Lett. 451: 81-94. doi:10.1016/S0014-5793(99)00550-5.
21. Murata-Hori, M., Fukuta, Y., Ueda, K., Iwasaki, T., and Hosoya, H. 2001. HeLa ZIP kinase induces diphosphorylation of myosin II regulatory light chain and reorganization of actin filaments in non-muscle cells. Oncogene, 20: 8175-8183. doi:10.1038/sj.onc.1205055.
22. 2+-free smooth muscle contraction via myosin light chain phosphorylation. J. Biol. Chem. 276: 29567-29574. doi:10.1074/jbc. M102753200.
23. Ozaki, H., Hori, M., Kinoshita, K., and Ohama, T. 2005. Intestinal dysmotility in inflammatory bowel disease: mechanisms of the reduced activity of smooth muscle contraction. Inflammopharmacology, 13: 103-111. doi:10.1163/156856005774423773.
24. Sato, N., Kamada, N., Muromoto, R., Kawai, T., Sugiyama, K., Watanabe, T., et al. 2006. Phosphorylation of threonine-265 in zipper-interacting protein kinase plays an important role in its activity and is induced by IL-6 family cytokines. Immunol. Lett. 103: 127-134. doi:10.1016/j.imlet.2005.10.015.
25. Trybus, K.M., and Chatman, T.A. 1993. Chimeric regulatory light chains as probes of smooth muscle myosin function. J. Biol. Chem. 268: 4412-4419.
26. Vrees, M.D., Pricolo, V.E., Potenti, F.M., and Cao, W. 2002. Abnormal motility in patients with ulcerative colitis: the role of inflammatory cytokines. Arch. Surg. 137: 439-445.
27. Walsh, M.P. 1991. Calcium-dependent mechanisms of regulation of smooth muscle contraction. Biochem. Cell Biol. 69: 771-800.
28. 2+-independent phosphorylation of myosin in rat caudal artery and chicken gizzard myofilaments. J. Physiol. 516: 805-824. doi:10.1111/j.1469-7793.1999.0805u.x.
29. 2+-independent myosin diphosphorylation and contraction of vascular smooth muscle. Biochem. J. 392: 641-648.